Jane Street’s Verrica Pharmaceuticals VRCA Stock Holding History

Jane Street’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$145K	Sell	23,654 -25,557	-52%	-$159K	﹤0.01%	10376
2026 Q1	$260K	Sell	49,211 -52,511	-52%	-$336K	﹤0.01%	9547
2025 Q4	$845K	Buy	+101,722	New	+$564K	﹤0.01%	6488
2025 Q3	–	Sell	-3,833	Closed	-$20.3K	–	11871
2025 Q2	$20.3K	Buy	+3,833	New	+$20.6K	﹤0.01%	9356
2025 Q1	–	Sell	-2,420	Closed	-$16.9K	–	10717
2024 Q4	$16.9K	Sell	2,420 -4,567	-65%	-$50.2K	﹤0.01%	9147
2024 Q3	$101K	Buy	6,987 +3,603	+106%	+$162K	﹤0.01%	8984
2024 Q2	$247K	Buy	+3,384	New	+$260K	﹤0.01%	8107
2024 Q1	–	Sell	-1,023	Closed	-$74.9K	–	10160
2023 Q4	$74.9K	Buy	+1,023	New	+$42K	﹤0.01%	8679
2023 Q2	–	Sell	-13,341	Closed	-$867K	–	9645
2023 Q1	$867K	Buy	13,341 +11,536	+639%	+$698K	﹤0.01%	5284
2022 Q4	$49.6K	Buy	+1,805	New	+$48.2K	﹤0.01%	8366
2022 Q3	–	Sell	-1,058	Closed	-$20K	–	10549
2022 Q2	$20K	Buy	+1,058	New	+$53.2K	﹤0.01%	9162

Other funds holding VRCA

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street's VRCA Position: Q2 2026 in Review

Jane Street reduced its Verrica Pharmaceuticals (VRCA) stake by 52% in Q2 2026, selling an estimated $159K and leaving 23,654 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #10376.

Jane Street first reported a position in VRCA in Q2 2022 and has held it in 11 quarters since. The position peaked at $867K in Q1 2023. 43 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

Jane Street held 23,654 shares of Verrica Pharmaceuticals worth $145K as of Q2 2026.
Jane Street sold 25,557 Verrica Pharmaceuticals shares in Q2 2026, an estimated $159K.
Verrica Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10376 holding.
Jane Street first reported a position in Verrica Pharmaceuticals in Q2 2022 and has held it in 11 quarters since.
Jane Street's Verrica Pharmaceuticals position peaked at $867K in Q1 2023.
43 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.